Q-omics provides the consensus-scored OR7E83P profile across patient tissues and cancer cell-line models. OR7E83P expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in LUAD. Among the 18 cancer types available for tumor–normal comparison, OR7E83P is differentially expressed in 4, with the highest sampling consensus in THCA. Additionally, OR7E83P RNA expression shows 11,759 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight LUAD, THCA, and THYM as cancer lineages where OR7E83P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR7E83P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR7E83P survival associations across molecular data types. OR7E83P RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR7E83P RNA expression–survival associations across cancer types. High OR7E83P expression shows unfavorable associations in LUAD, MESO, BRCA, KICH, STAD and PCPG. The LUAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LUAD as the clearest survival context for OR7E83P RNA expression.
This table summarizes OR7E83P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for OR7E83P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR7E83P shows lower tumor expression in THCA and PRAD and higher tumor expression in UCEC and BRCA. The THCA box plot shows higher OR7E83P RNA expression in normal versus tumor tissue (log2 FC = −0.742, t-test p < 0.001).
This table shows molecular features associated with OR7E83P in patient tissues and cancer cell lines. In patient samples, OR7E83P shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
